Literature DB >> 16210721

Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women.

Biljana Miljanović1, Komal A Trivedi, M Reza Dana, Jeffery P Gilbard, Julie E Buring, Debra A Schaumberg.   

Abstract

BACKGROUND: Dry eye syndrome (DES) is a prevalent condition, but information on risk or protective factors is lacking.
OBJECTIVE: We aimed to determine the association between the dietary intake and ratio of n-3 and n-6 fatty acids (FAs) and DES occurrence.
DESIGN: Of the 39876 female health professionals in the Women's Health Study (WHS), 32470 women aged 45-84 y who provided information on diet and DES were cross-sectionally studied. We assessed FA intakes by using a validated food-frequency questionnaire and assessed DES by using self-reports of clinically diagnosed cases. Of the sample, 1546 (4.7%) subjects reported DES. We used logistic regression models to estimate the odds ratios (ORs) and 95% CIs to describe the relation of FA intake with DES.
RESULTS: After adjustment for demographic factors, hormone therapy, and total fat intake, the OR for the highest versus the lowest quintile of n-3 FAs was 0.83 (95% CI: 0.70, 0.98; P for trend = 0.05). A higher ratio of n-6 to n-3 FA consumption was associated with a significantly increased risk of DES (OR: 2.51; 95% CI: 1.13, 5.58) for >15:1 versus <4:1 (P for trend = 0.01). In addition, tuna consumption [1 serving was 113 g (4 oz)] was inversely associated with DES (OR: 0.81; 95% CI: 0.66, 0.99 for 2-4 servings/wk; OR: 0.32; 95% CI: 0.13, 0.79 for 5-6 servings/wk versus < or =1 serving/wk; P for trend = 0.005).
CONCLUSIONS: These results suggest that a higher dietary intake of n-3 FAs is associated with a decreased incidence of DES in women. These findings are consistent with anecdotal clinical observations and postulated biological mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210721      PMCID: PMC1360504          DOI: 10.1093/ajcn/82.4.887

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  33 in total

1.  Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.

Authors:  A Solomon; D Dursun; Z Liu; Y Xie; A Macri; S C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-09       Impact factor: 4.799

Review 2.  A new look at dry eye disease and its treatment.

Authors:  J D Nelson; H Helms; R Fiscella; Y Southwell; J D Hirsch
Journal:  Adv Ther       Date:  2000 Mar-Apr       Impact factor: 3.845

Review 3.  Human requirement for N-3 polyunsaturated fatty acids.

Authors:  A P Simopoulos
Journal:  Poult Sci       Date:  2000-07       Impact factor: 3.352

Review 4.  Omega-3 fatty acids as cancer chemopreventive agents.

Authors:  D P Rose; J M Connolly
Journal:  Pharmacol Ther       Date:  1999-09       Impact factor: 12.310

5.  Dry eye and dry mouth in the elderly: a population-based assessment.

Authors:  O D Schein; M C Hochberg; B Muñoz; J M Tielsch; K Bandeen-Roche; T Provost; G J Anhalt; S West
Journal:  Arch Intern Med       Date:  1999-06-28

Review 6.  Polyunsaturated fatty acids and rheumatoid arthritis.

Authors:  P C Calder; R B Zurier
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2001-03       Impact factor: 4.294

7.  Prevalence of and risk factors for dry eye syndrome.

Authors:  S E Moss; R Klein; B E Klein
Journal:  Arch Ophthalmol       Date:  2000-09

8.  Cox-2 inhibitory effects of naturally occurring and modified fatty acids.

Authors:  T Ringbom; U Huss; A Stenholm ; S Flock; L Skattebøl; P Perera; L Bohlin
Journal:  J Nat Prod       Date:  2001-06       Impact factor: 4.050

9.  Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes.

Authors:  K S Kunert; A S Tisdale; M E Stern; J A Smith; I K Gipson
Journal:  Arch Ophthalmol       Date:  2000-11

10.  Intake of fish and omega-3 fatty acids and risk of stroke in women.

Authors:  H Iso; K M Rexrode; M J Stampfer; J E Manson; G A Colditz; F E Speizer; C H Hennekens; W C Willett
Journal:  JAMA       Date:  2001-01-17       Impact factor: 56.272

View more
  66 in total

1.  Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model.

Authors:  Na Li; Jiucheng He; Carl Eric Schwartz; Per Gjorstrup; Haydee E P Bazan
Journal:  J Ocul Pharmacol Ther       Date:  2010-10       Impact factor: 2.671

Review 2.  Lifestyle exposures and eye diseases in adults.

Authors:  Barbara E K Klein; Ronald Klein
Journal:  Am J Ophthalmol       Date:  2007-10-18       Impact factor: 5.258

3.  The Dry Eye Assessment and Management (DREAM) extension study - A randomized clinical trial of withdrawal of supplementation with omega-3 fatty acid in patients with dry eye disease.

Authors:  Munira Hussain; Roni M Shtein; Maxwell Pistilli; Maureen G Maguire; Marko Oydanich; Penny A Asbell
Journal:  Ocul Surf       Date:  2019-08-16       Impact factor: 5.033

4.  Tear dysfunction and the cornea: LXVIII Edward Jackson Memorial Lecture.

Authors:  Stephen C Pflugfelder
Journal:  Am J Ophthalmol       Date:  2011-10-22       Impact factor: 5.258

5.  Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women.

Authors:  William G Christen; Debra A Schaumberg; Robert J Glynn; Julie E Buring
Journal:  Arch Ophthalmol       Date:  2011-03-14

Review 6.  Omega-3 fatty acids in dry eye and corneal nerve regeneration after refractive surgery.

Authors:  Jiucheng He; Haydee E P Bazan
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-03-03       Impact factor: 4.006

Review 7.  The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction.

Authors:  Gerd Geerling; Joseph Tauber; Christophe Baudouin; Eiki Goto; Yukihiro Matsumoto; Terrence O'Brien; Maurizio Rolando; Kazuo Tsubota; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 8.  The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD.

Authors:  Debra A Schaumberg; Jason J Nichols; Eric B Papas; Louis Tong; Miki Uchino; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

9.  Omega-3 fatty acids: An update emphasizing clinical use.

Authors:  David Kiefer; Traci Pantuso
Journal:  Agro Food Ind Hi Tech       Date:  2012-07

10.  Etiology, prevalence, and treatment of dry eye disease.

Authors:  Johnny L Gayton
Journal:  Clin Ophthalmol       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.